Oxygenta Pharmaceutical Ltd vs Samrat Pharmachem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 11, 2026

Key Highlights

The Latest Trading Price of Oxygenta Pharmaceutical Ltd is ₹ 43 as of 11 Jun 15:07 . The P/E Ratio of Oxygenta Pharmaceutical Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Samrat Pharmachem Ltd changed from 7.9 on March 2021 to 13.6 on March 2025 . This represents a CAGR of 11.48% over 5 years The Market Cap of Oxygenta Pharmaceutical Ltd changed from ₹ 34.15 crore on March 2022 to ₹ 294.24 crore on March 2025 . This represents a CAGR of 71.33% over 4 yearsThe Market Cap of Samrat Pharmachem Ltd changed from ₹ 42.02 crore on March 2021 to ₹ 96.63 crore on March 2025 . This represents a CAGR of 18.12% over 5 years The revenue of Oxygenta Pharmaceutical Ltd for the Mar '26 is ₹ 49.79 crore as compare to the Dec '25 revenue of ₹ 33.93 crore. This represent the growth of 46.74% The revenue of Samrat Pharmachem Ltd for the Mar '26 is ₹ 71.47 crore as compare to the Dec '25 revenue of ₹ 63.83 crore. This represent the growth of 11.97% The ebitda of Oxygenta Pharmaceutical Ltd for the Mar '26 is ₹ 0.29 crore as compare to the Dec '25 ebitda of ₹ -4.08 crore. This represent the decline of -107% The ebitda of Samrat Pharmachem Ltd for the Mar '26 is ₹ -1.55 crore as compare to the Dec '25 ebitda of ₹ -0.26 crore. This represent the growth of 496.15% The net profit of Oxygenta Pharmaceutical Ltd changed from ₹ -1.36 crore to ₹ -1.7 crore over 8 quarters. This represents a CAGR of 11.80% The net profit of Samrat Pharmachem Ltd changed from ₹ 2.07 crore to ₹ -2.04 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Oxygenta Pharmaceutical Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Samrat Pharmachem Ltd changed from 1.8 % on March 2022 to 4.35 % on March 2025 . This represents a CAGR of 24.68% over 4 years .

About Oxygenta Pharmaceutical Ltd

Oxygenta Pharmaceutical Limited was initially incorporated as S S Organics Private Limited as a private limited Company in 1990.
The Company converted its status to a Public Limited Company in 1993 changing the name to S S Organics Limited.
Further, it was changed to Oxygenta Pharmaceutical Limited in FY 2021-22. The Company was incorporated with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals.
It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs.
The Company has plant located at Medak in Andhra Pradesh. The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs.

About Samrat Pharmachem Ltd

Samrat Pharmachem Limited was incorporated on June 16, 1992 at Ankleshwar in Gujarat led by the Promoters, Mr. Lalit Mehta & Mr. Rajesh Mehta.
Since then, it envisioned to focus on lodine Derivatives as their core products.
The Company's principal activities are manufacturing and selling chemicals.
Company is a producer of pharmaceutical chemicals.
The intermediates produced are used in pharmaceutical and chemical industries.

FAQs for the comparison of Oxygenta Pharmaceutical Ltd and Samrat Pharmachem Ltd

Which company has a larger market capitalization, Oxygenta Pharmaceutical Ltd or Samrat Pharmachem Ltd?

Market cap of Oxygenta Pharmaceutical Ltd is 179 Cr while Market cap of Samrat Pharmachem Ltd is 63 Cr

What are the key factors driving the stock performance of Oxygenta Pharmaceutical Ltd and Samrat Pharmachem Ltd?

The stock performance of Oxygenta Pharmaceutical Ltd and Samrat Pharmachem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Oxygenta Pharmaceutical Ltd and Samrat Pharmachem Ltd?

As of June 11, 2026, the Oxygenta Pharmaceutical Ltd stock price is INR ₹48.41. On the other hand, Samrat Pharmachem Ltd stock price is INR ₹205.0.

How do dividend payouts of Oxygenta Pharmaceutical Ltd and Samrat Pharmachem Ltd compare?

To compare the dividend payouts of Oxygenta Pharmaceutical Ltd and Samrat Pharmachem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.